NCT01315314View on ClinicalTrials.gov

Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Kidney Failure, ChronicDisorders Associated With Peritoneal Dialysis
Interventions
DRUG

Balance, Fresenius Medical Care, Germany

low glucose degradation product (GDP)-containing peritoneal dialysis fluid (PDF)

Trial Locations (1)

700-721

Division of Nephrology and Department of Internal Medicine, Kyungpook National University Hospital, Daegu

All Listed Sponsors
collaborator

Ministry of Health & Welfare, Korea

OTHER_GOV

collaborator

Fresenius Medical Care Korea

INDUSTRY

lead

Kyungpook National University Hospital

OTHER

NCT01315314 - Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction | Biotech Hunter | Biotech Hunter